INTRODUCTION
It is well established that tyrosine phosphorylation plays an essential role in the activation of signal transduction by immunoreceptors whose cytoplasmic domains contain the conserved immunoreceptor tyrosine-based activation motif (ITAM; reviewed in refs. [1] [2] [3] ). The ITAM consists of two conserved tyrosine/leucinecontaining sequences (YXXL/I) separated by six to 12 nonconserved amino acids and becomes phosphorylated on tyrosine following binding of ligand at the cell surface. The ITAM acts as a docking site for Src homology 2 (SH2)-containing proteins, including the tyrosine kinase Syk, a key activator in downstream signaling pathways. These early activating events ultimately result in positive biological responses including, in the case of several members of the Fc receptor for immunoglobulin G (Fc␥R) family, the phagocytosis of immunoglobulin (IgG)-coated particles, the endocytosis of immune complexes, and the release of inflammatory mediators.
Inhibitory receptors, which negatively regulate signal-transduction events, have been identified in a wide variety of cell types [4, 5] . They include the Fc␥R, Fc␥RIIB, expressed in B cells, mast cells, and monocytes; killer cell Ig-like receptors (KIR), expressed in natural killer and T cells; and the paired Ig-like receptor PiR-B, expressed in mast and B cells [6 -9] . These inhibitory receptors have one or more tyrosine-containing immunoreceptor tyrosine-based inhibition motif (ITIM) sequences in their cytoplasmic domains. The ITIM resembles the ITAM in that it contains a tyrosine/leucine motif (YXXL/I). However, in inhibitory receptors, a single YXXL sequence is embedded within a 13 amino acid sequence that typically contains a hydrophobic residue at the -2 position [10] .
Coaggregation of ITAM-and ITIM-containing receptors by an extracellular ligand is required to trigger ITIM-mediated inhibition of cellular signaling responses. Following coaggregation, the cytoplasmic ITIMs undergo tyrosine phosphorylation and may recruit SH2-containing proteins. The inhibitory action of ITIMcontaining receptors has been linked to the recruitment of proteins such as the SH2-containing tyrosine phosphatases (SHP) SHP-1 and SHP-2 and the SH2 domain containing inositol phosphatases (SHIP) SHIP-1 and SHIP-2 [11] .
We have demonstrated that Fc␥RIIB can inhibit Fc␥R-mediated phagocytic pathways [12] . In COS-1 cells, coligation of human Fc␥RIIA and Fc␥RIIB results in a dramatic reduction in the efficiency of Fc␥RIIA-mediated phagocytosis. The inhibitory action of Fc␥RIIB on Fc␥RIIA-mediated signaling is of interest, considering the homology of the extracellular domains of these two Fc␥RII receptors [13] . Both receptors bind the Fc portion of most IgGs and therefore are stimulated by the same ligands. Thus, in cells in which Fc␥RIIA and Fc␥RIIB are coexpressed, such as human monocytes and macrophages [6] , stimulation by IgG complexes could potentially elicit both positive and negative responses.
The inhibitory action of Fc␥RIIB in B cells, mast cells, and monocytes has been linked to the activation of the inositol phosphatase SHIP-1 [14] . However, our observation that the reduction in phagocytic efficiency following coclustering of Fc␥RIIA and Fc␥RIIB in COS-1 cells is accompanied by a dramatic reduction in the tyrosine phosphorylation of Fc␥RIIA suggested a role for a tyrosine phosphatase such as SHP-1 in modulating the Fc␥RIIA phagocytic response [12] . A recent report that overexpression of SHP-1 in a macrophage cell line reduces phagocytic efficiency supports this theory [15] . Since tyrosine phosphorylation of Fc␥RIIA is a crucial, early activation step in the Fc␥RIIA-mediated signaling pathway [1] , we have now examined the ability of SHP-1 to inhibit Fc␥RIIA-mediated phagocytosis. Our present studies indicate that both tyrosine (SHP-1) and inositol (SHIP-1) phosphatases enhance Fc␥RIIB-mediated inhibition of phagocytosis by Fc␥RIIA and that SHP-1 enhances the inhibition of Fc␥RIIA tyrosine phosphorylation. We also observed that overexpression of SHP-1 has a dramatic effect on the tyrosine phosphorylation of Syk kinase, a crucial downstream activator of Fc␥RIIA signaling. In addition, tyrosine phosphorylation of SHP-1 is enhanced following stimulation of Fc␥RIIA and Fc␥RIIB in COS-1 cells as well as in peripheral blood monocytes.
It is interesting that even in the absence of the inhibitory Fc␥RIIB receptor, overexpression of SHP-1 or SHIP-1 in COS-1 cells significantly inhibits Fc␥RIIA-mediated phagocytosis, and that SHP-1 also inhibits Fc␥RIIA tyrosine phosphorylation. In addition, we demonstrate that Fc␥RIIA itself can activate SHP-1 in the absence of an inhibitory receptor. These observations support the thesis that the tyrosine and inositol phosphatases SHP-1 and SHIP-1 have the ability to modulate ITAM-containing receptors in the absence of ITIM-containing inhibitory receptors [14, 15] .
MATERIALS AND METHODS

Antibodies and cDNAs
The anti-Syk monoclonal antibody (mAb; 4D10), anti-SHP-1 polyclonal antibody (C-19), anti-Myc mAb (9E10), and its agarose conjugate were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). An antiphosphotyrosine mAb (4G10) and the anti-Syk polyclonal rabbit antibody were purchased from Upstate Biotechnology (Lake Placid, NY). The antihemagglutinin (anti-HA) rat mAb (3F10) was purchased from Roche Diagnostics (Indianapolis, IN). The anti-Fc␥RII mAb (IV.3) was from Medarex (Princeton, NJ), and the goat affinity-purified F(abЈ) 2 fragment to mouse IgG was purchased from ICN Biomedicals (Aurora, OH). Rabbit anti-sheep red blood cell (RBC) antibody was from Cappel Laboratories (West Chester, PA). All cDNAs were subcloned into the mammalian expression vector pcDNA3.1. Human Fc␥RIIA was tagged with the Myc/histidine epitope. Fc␥RIIB was tagged with the HA epitope. SHIP-1 cDNA was also tagged with the HA epitope. Dr. Benjamin Neel (Harvard Institute of Medicine, Boston, MA) kindly provided the pcDNA3.1/ SHP-1 plasmid. The phosphatase-negative mutant of SHP-1, which lacks the phosphatase domain (residues 220 -595), was generated by polymerase chain reaction and inserted into pcDNA3.
Cell culture and transfection
COS-1 cells were maintained in Dulbecco's modified Eagle's medium containing glucose (4.5 mg/ml), glutamine (2 mmol/L), streptomycin (100 U/ml), penicillin (100 mg/ml), and 10% heat-inactivated fetal calf serum (FCS). Transient transfection of cells at 70 -80% confluence was performed in complete media containing diethylaminoethyl-dextran (0.6 mg/ml), chloroquine chloride (100 mmol/L), and 4 g plasmid DNA per milliliter of transfection media. After 4 h at 37°C, the transfection medium was replaced with 10% dimethyl sulfoxide in phosphatebuffered saline (PBS) for 90 s at room temperature. The cells were then washed, overlaid with fresh media for further incubation, and analyzed after 48 h. The expression of transfected receptors was analyzed by flow cytometry and/or by immunoblotting aliquots of cell lysates.
Flow cytometry
Cell samples incubated with anti-Fc␥RII mAb IV.3 for 30 min at 4°C were washed, labeled with fluorescein isothiocyanate-conjugated goat anti-mouse IgG (G␣M) F(abЈ) 2 (Tago, Inc., Burlingame, CA) for 30 min at 4°C, and then washed and fixed with 4% paraformaldehyde. Isotype controls were used for all reactions, and fluorescence was measured on a Becton Dickinson FACScan (Mansfield, MA). For all samples, 5000 events were recorded on a logarithmic fluorescence scale.
Immunoprecipitation and Western blotting
Transfected cells were lysed directly on culture plates with Brij 96 lysis buffer (1% Brij 96, 5 mmol/L Hepes-KOH, pH 7.4) in the presence of the protease and phosphatase inhibitors, 5 mM EGTA, 3 mM Na orthovanadate, 2 mM phenylmethylsulfonyl fluoride, and 10 mg/L aprotinin and leupeptin (Sigma Chemical Co., St. Louis, MO). Following centrifugation at 12,000 rpm for 30 min at 4°C, the lysates were precleared by incubation with protein G or A plus agarose (Santa Cruz Biotechnology) and then incubated overnight at 4°C with appropriate antibodies. Immune complexes were bound to protein G or A plus agarose in lysis buffer. Pellets were washed three times in lysis buffer and adsorbed proteins, eluted into reducing or nonreducing sample buffer, and resolved on 7.5% or 10% sodium dodecyl sulfate-polyacrylamide gels. Following electrophoretic transfer to nitrocellulose, proteins were immunoblotted with appropriate blotting antibodies. Blots were developed with horseradish peroxidase-conjugated G␣M or goat anti-rabbit IgG (Santa Cruz Biotechnology). The specific bands were detected by enhanced chemiluminescence (Amersham, Arlington Heights, IL).
Preparation of antibody-sensitized sheep erythrocytes and analysis of phagocytosis
Antibody-sensitized sheep erythrocytes (EA) were prepared in magnesiumand calcium-free PBS by incubating 10 9 /ml sheep RBCs (Rockland, Gilbertsville, PA) with an equal volume of the highest subagglutinating concentration of rabbit anti-sheep RBC antibody (Cappel Laboratories). COS-1 cells were incubated with EA at 37°C for 30 min, and unbound EA were removed by washing with PBS. To assess phagocytosis, externally bound RBCs were removed by brief hypotonic shock. The cells were then stained with Wright'sGiemsa, and the number of COS-1 cells with one or more internalized EA was determined in a blinded manner. The phagocytic index (PI) is calculated as the number of ingested RBCs/100 cells and is adjusted to reflect expression of the transfected DNA determined by flow cytometry.
Monocyte isolation and culture
Peripheral blood mononuclear cells from healthy individuals were isolated as described previously [16] . Briefly, the heparinized blood was centrifuged on Ficoll-Hypaque (Lymphocyte Separation Medium; Organon Teknika, Durham, NC), and interface cells were washed twice in PBS. Mononuclear cells were resuspended in complete medium containing RPMI 1640 (Life Technologies, Grand Island, NY) with 10% heat-inactivated FCS and 2 mM L-glutamine. Cells were allowed to adhere at 37°C onto tissue-culture flasks precoated with FCS. After 45-60 min, nonadherent cells were removed by extensive washing in PBS. Cells were harvested by vigorous agitation. Isolated monocytes were maintained in RPMI 1640 supplemented with L-glutamine (2 mM) and 10% heat-inactivated FCS at 37°C in 5% CO 2 .
RESULTS
SHP-1 and SHIP-1 phosphatases enhance Fc␥RIIB-mediated inhibition of phagocytosis by Fc␥RIIA
Fc␥RIIB is a nonphagocytic member of the Fc␥R family expressed on a variety of cells of the immune system including monocytes [6] . It has been classified as an inhibitory receptor as a result of the presence of the ITIM sequence in its cytoplasmic domain, and it has been shown to attenuate immune responses in B cells, mast cells, and monocytes following coaggregation with ITAM-containing immunoreceptors [5] . In a previous study, we demonstrated that Fc␥RIIB inhibits Fc␥RIIA-mediated phagocytosis of IgG-coated EA by up to 50% in transfected COS-1 cells [12] . To determine whether the phosphatases SHP-1 and SHIP-1 augment the inhibitory effect of Fc␥RIIB on Fc␥RIIA function, we examined Fc␥RIIA-mediated phagocytosis in COS-1 cells cotransfected with the Fc␥RII receptors and these phosphatases.
As we previously reported, treatment with EA coaggregates Fc␥RIIB and Fc␥RIIA and reduces Fc␥RIIA-mediated phagocytosis by ϳ50% ( Table 1 ) [12] . In cells cotransfected with SHP-1 or SHIP-1, the inhibitory effect of Fc␥RIIB increases from 50% to 85%. The reduction in phagocytosis was not a result of differences in the levels of Fc␥RIIA expression, since Western blot analysis determined that receptor expression within each experiment was constant (not shown). Although a role for the inositol phosphatase SHIP-1 in signaling by the inhibitory Fc␥RIIB receptor has been described in B cells and in monocytes [17] [18] [19] [20] , we were interested in investigating whether SHP-1 plays a role in Fc␥RIIB-mediated inhibition of Fc␥R signaling in monocytes. The enhancement of inhibition observed when SHP-1 was coexpressed with Fc␥RIIB suggests that this tyrosine phosphatase interacts with Fc␥RIIB to modulate Fc␥RIIA-mediated phagocytosis.
SHP-1 and SHIP-1 affect Fc␥RIIA-mediated phagocytic signaling even in the absence of Fc␥RIIB (Table 1) . Coexpression of either phosphatase with Fc␥RIIA alone decreased Fc␥RIIA-mediated phagocytosis by Ͼ50%. We determined by flow cytometry and by Western blot that the decrease in phagocytosis was not a result of a decrease in the cell-surface expression or level of Fc␥RIIA protein (not shown). This observation suggests that both SHP-1 and SHIP-1 can interact with the Fc␥RIIA signaling process directly, and although the effect on phagocytosis was less potent than that of Fc␥RIIB and the phosphatases combined, the phosphatases do not necessarily require an ITIM-containing receptor to be recruited to the signaling machinery following stimulation of an "activating" receptor.
The effect of SHP-1 on tyrosine phosphorylation of Fc␥RIIA Tyrosine phosphorylation of the Fc␥RIIA ITAM is an important and necessary step in signal-transduction pathways stemming from the stimulation of Fc␥RIIA and is required to mediate the phagocytic signal [1] . Our previous studies indicated that inhibition of Fc␥RIIA-mediated phagocytosis by Fc␥RIIB is accompanied by a decrease in tyrosine phosphorylation of the Fc␥RIIA receptor itself in transfected COS-1 cells [12] . Coexpression of the tyrosine phosphatase SHP-1 with Fc␥RIIA and Fc␥RIIB results in further reduction of Fc␥RIIA tyrosine phosphorylation in transfected cells incubated with EA (Fig. 1) . The observation that overexpression of SHP-1 enhances the inhibition of Fc␥RIIA tyrosine phosphorylation by Fc␥RIIB suggests that SHP-1 can be recruited by the Fc␥RIIA/Fc␥RIIB receptor complex in these cells, resulting in the dephosphorylation of Fc␥RIIA.
SHP-1 expression also inhibited the tyrosine phosphorylation of Fc␥RIIA in the absence of Fc␥RIIB expression (Fig. 1,  compare lanes 1 and 4) . Although the decrease in tyrosine phosphorylation of Fc␥RIIA is not as dramatic as that observed when Fc␥RIIB is also present (lane 3), these data suggest that the activating Fc␥RIIA receptor itself interacts with SHP-1 and has the potential to modulate its own signaling pathways. The interaction of Fc␥RIIA and SHP-1 that results in decreased tyrosine phosphorylation of Fc␥RIIA may involve direct interaction of the SHP-1 SH2 domains with the ITAM itself or may involve an intermediary substrate in the receptor complex, such as a Src-related tyrosine kinase (SRTK) or Syk, a key molecule in the Fc␥RIIA-mediated pathway leading to phagocytosis.
In contrast to SHP-1, the inositol phosphatase SHIP-1 (although dramatically reducing Fc␥RIIA-mediated phagocytosis) had no effect on Fc␥RIIA tyrosine phosphorylation (not shown). This contrast highlights the distinct pathways that these tyrosine and inositol phosphatases use to attenuate signaling cascades. Inhibition of phagocytosis is expressed as the % reduction in Fc␥RIIA-mediated phagocytosis. Phagocytosis is measured as the PI (the number of EA ingested per 100 cells) in each experiment, and 600 -900 cells were counted in each case.
The effect of the tyrosine phosphatase SHP-1 on the activation of Syk kinase Syk kinase plays an essential role in the activation pathway leading to Fc␥R-mediated phagocytosis in monocytes, and overexpression of Syk enhances Fc␥R-mediated phagocytosis in transfected epithelial cells [1] . Having demonstrated that SHP-1 expression results in a decrease in Fc␥RIIA-mediated phagocytosis and Fc␥RIIA tyrosine phosphorylation, we examined whether overexpression of SHP-1 also affects the activation of Syk. Cross-linking Fc␥RIIA with anti-Fc␥RII mAb IV.3 (whole IgG) and G␣M F(abЈ) 2 in COS-1 cells expressing Fc␥RIIA and Syk kinase produced a dramatic increase in the tyrosine phosphorylation of Syk (1 and Fig. 2 , top, lane 1 vs. 5). Fc␥RII cross-linking in cells coexpressing Fc␥RIIB with Fc␥RIIA and Syk did not noticeably affect the tyrosine phosphorylation of Syk (Fig. 2, top, lane 4) . However, overexpression of SHP-1 in the presence and absence of Fc␥RIIB (Fig. 2 , top, lanes 2 and 3) reduced Syk tyrosine phosphorylation to a level comparable with that in unstimulated cells (Fig. 2, top,  lane 1) . We also observed that SHP-1 coimmunoprecipitates with Syk (Fig. 2, middle, lanes 2 and 3) .
The phosphatase activity of SHP-1 is directly responsible for the observed decrease in phosphorylation of Syk, since a phosphatase-negative mutant of SHP-1 did not inhibit the tyrosine phosphorylation of Syk following Fc␥R stimulation of COS-1 cells expressing Fc␥RIIA, Fc␥RIIB, SHP-1, and Syk (Fig. 3A, lane 4) . SHP-1 also decreased the tyrosine phosphorylation of Syk in the absence of Fc␥RIIB expression (Fig.  3A, lane 5) , and phosphatase-negative SHP-1 also had no effect on Syk tyrosine phosphorylation in the absence of Fc␥RIIB expression (Fig. 3A, lane 6) . In similar experiments, coexpression of the inositol phosphatase SHIP-1 had no effect on the tyrosine phosphorylation of Syk kinase (Fig. 3B, lane 4) .
The effect of Fc␥R cross-linking on the tyrosine phosphorylation of SHP-1
We examined whether stimulation of Fc␥Rs affects tyrosine phosphorylation (activation) of SHP-1 in transiently transfected COS-1 cells and in human monocytes. COS-1 cells transfected with SHP-1 and only the Fc␥RIIB inhibitory receptor were incubated with anti-Fc␥RII mAb IV.3 (whole IgG) and crosslinked with G␣M F(abЈ) 2 at 37°C for 1 and 5 min (Fig. 4A) . SHP-1 was strongly phosphorylated on tyrosine following 1 and 5 min stimulation of Fc␥RIIB (lanes 2 and 3) . In the absence of Fc␥RIIB stimulation, tyrosine phosphorylation of SHP-1 was not detected (lane 1). This not only demonstrates the ability of Fc␥RIIB to stimulate the tyrosine phosphorylation of SHP-1 but also demonstrates the ability of mAb IV.3 to bind and stimulate Fc␥RIIB. SHP-1 was also tyrosine-phosphorylated following Fc␥RIIA stimulation in cells cotransfected with SHP-1 and only Fc␥RIIA (Fig. 4A, lanes 5 and 6) . Again, in the absence of Fc␥RIIA stimulation with mAb IV.3, there was no tyrosine phosphorylation of SHP-1 (lane 4).
We next examined the tyrosine phosphorylation of SHP-1 in COS-1 cells expressing Fc␥RIIA, Fc␥RIIB, and SHP-1 (Fig.  4B) . The Fc␥Rs were costimulated with mAb IV.3 (whole IgG) for 1, 5, 15, and 30 min. SHP-1 was heavily tyrosine-phosphorylated after 1 min (Fig. 4B, lane 4) . After 30 min stimulation, tyrosine phosphorylation of SHP-1 diminished (lane 7). In unstimulated cells (cells incubated at 0, 5, or 30 min in the absence of the stimulating mAb IV.3), there was no detectable activation of SHP-1 tyrosine phosphorylation (lanes 1-3) . In each case (A and B) , the amount of SHP-1 in the immunoprecipitates does not account for the differences in tyrosine phosphorylation of SHP-1.
To determine whether SHP-1 is involved in the inhibitory action of Fc␥RIIB in monocytes/macrophages, we examined SHP-1 tyrosine phosphorylation in human monocytes (Fig. 4C) , which express Fc␥RIIA and Fc␥RIIB [6, 19, 20] . As we have demonstrated, mAb IV.3 recognizes both of these Fc␥RII receptors (Fig. 4A) . Following stimulation of Fc␥RII with mAb IV.3 (whole IgG), SHP-1 tyrosine phosphorylation was clearly detectable on immunoblots after 1 min (Fig. 4C, lane 2) .
We have also observed the association of SHP-1 with Fc␥RIIB (Fig. 5) . We immunoprecipitated SHP-1 from COS-1 cell lysates expressing SHP-1 and Fc␥RIIB (Fig. 5) . Following 1 min of stimulation with mAb IV.3, a substantial amount of Fc␥RIIB coprecipitated with SHP-1 (lane 1). By 30 min stimulation, the amount of Fc␥RIIB associated with SHP-1 had declined (lane 2), and in the absence of Fc␥RIIB stimulation, the Fc␥RIIB associated with SHP-1 was barely detectable (lane 3). In similar experiments, we were unable to detect coprecipitation of Fc␥RIIA with SHP-1 (not shown).
DISCUSSION
Inositol (SHIP) and tyrosine (SHP) phosphatases have been implicated in Fc␥RIIB-mediated attenuation of B cell and mast cell responses, and in mouse macrophages, both phosphatases have been associated with the inhibition of Fc␥R phagocytosis [15, 20 -24] . Following recruitment to the receptor complex at the cell membrane, SHP-1 is thought to inhibit cellular responses by dephosphorylating tyrosines on substrates crucial for signaling. Possible substrates include the ITAM of the activating receptor itself, Syk family kinases, phospholipase C␥ (PLC␥), and adaptor proteins such as SLP76 [25, 26] . Our previous data suggested that recruitment of a tyrosine phosphatase is associated with the suppression of Fc␥RIIA-medi- ated phagocytosis by Fc␥RIIB. Our present data demonstrate that overexpression of the tyrosine phosphatase SHP-1 in COS-1 cells enhances the ability of Fc␥RIIB to inhibit Fc␥RIIA-mediated phagocytosis and suggest that the tyrosine phosphatase SHP-1 interacts with Fc␥RIIB in vivo ( Table 1) .
The phosphorylated Fc␥RIIB ITIM is capable of binding SHP-1 and SHIP-1 phosphatases [23, 24] . However, studies on Fc␥RIIB-mediated modulation of Fc␥R signaling in monocytes and macrophages have focused on the role of the inositol phosphatase SHIP-1. For example, in macrophages from SHIP-1 Ϫ/Ϫ mice, FcR-mediated phagocytosis is enhanced compared with macrophages from SHIP-1 ϩ/ϩ mice [20] , and in human monocytes, coclustering of Fc␥RIIB and Fc␥RIIA or Fc␥RI receptors results in the stimulation of SHIP-1 tyrosine phosphorylation [14, 19] . SHIP-1 inhibits signaling pathways through the dephosphorylation of phosphatidylinositol triphosphate (PIP3) [3, 4, 5] , a product of the phosphatidylinositol-3 kinase signaling pathway. A consequence of SHIP-1 activation is the attenuation of PIP3-dependent events, e.g., the translocation of Tec family kinases such as Akt and Btk (required for the activation of PLC␥) to the plasma membrane [27, 28] . These findings suggest a role for inositol phosphatases in the Fc␥RIIB-mediated inhibition of Fc␥R signal transduction in monocytic cells. Our data also support a role for SHIP-1 in this inhibitory process, since coexpression of SHIP-1 with Fc␥RIIA and Fc␥RIIB enhances Fc␥RIIB-mediated inhibition of phagocytosis by Fc␥RIIA (Table 1) .
Our data provide evidence that the tyrosine phosphatase SHP-1 is also involved in the Fc␥RIIB-mediated inhibition of Fc␥RIIA signaling in phagocytic cells. Coexpression of SHP-1 enhances the Fc␥RIIB-mediated inhibition of Fc␥RIIA phagocytosis and the Fc␥RIIB-mediated decrease in tyrosine phosphorylation of Fc␥RIIA in transfected COS-1 cells (Table 1 and Fig. 1) . Furthermore, activation of Fc␥RII receptors results in the stimulation of SHP-1 tyrosine phosphorylation in COS-1 cells and in human monocytes (Fig. 4C) . Both Fc␥RIIA and Fc␥RIIB are expressed in human monocytes [6, 19, 29] , and the extent to which SHP-1 interacts with Fc␥RIIB in monocytes is difficult to quantify. (mAb IV.3 is capable of binding to both of these Fc␥RII receptors; unpublished results and Fig.  4A .) The recent demonstration that Fc␥RIIB expression in monocytes can be regulated by cytokines suggests that the mechanisms used by Fc␥RIIB to down-regulate Fc␥RIIA signal transduction may depend on the relative expression of the two Fc␥RII receptors [19, 29] . However, even if the relative expression of Fc␥RIIB is low compared with the expression of Fc␥RIIA, our data clearly demonstrate that the tyrosine phosphatase SHP-1 is activated in human monocytes following Fc␥RII stimulation and is likely to play a role in the inhibition of Fc␥R-mediated signaling in vivo.
Recent studies, using peptides containing the phosphorylated Fc␥RIIB ITIM sequence (pITIM), have suggested that Fc␥RIIB binds more avidly to SHIP-1 than to SHP-1 and consequently, preferentially uses SHIP-1 in vivo [21] . In these studies, coprecipitation of the Fc␥RIIB pITIM and SHP-1 was detected by immunoblot only if there were a high level of tyrosine phosphorylation of the ITIM peptides (e.g., following in vitro phosphorylation of the ITIM by an SRTK). The binding of SHP-1 to the Fc␥RIIB ITIM was also detectable on immunoblot in pervanadate-treated cells [21] , where phosphatases are inhibited, and tyrosine phosphorylation levels consequently remain relatively high. We have observed coprecipitation of Fc␥RIIB and SHP-1 in our COS-1 cell model (Fig. 5) . It is possible that the relatively high level of Fc␥RIIB and SHP-1 expression in our transfected COS-1 cells facilitates detection of the interaction of SHP-1 and Fc␥RIIB.
Tyrosine phosphatases such as SHP-1 are recruited to pITIMs via their SH2 domains, and it has been suggested that to be recruited to receptor complexes, tyrosine phosphatases may require both SH2 domains to be engaged [21] . Such a requirement is consistent with reports that SHP-1 is involved in the inhibitory responses mediated by such receptors as the KIR, PIR-B, and the platelet-endothelial cell adhesion molecule receptor, all of which contain more than one ITIM. Although Fc␥RIIB contains a single ITIM sequence, one possibility is that SHP-1 may be recruited to the Fc␥RIIA/Fc␥IIB receptor complex by interacting with phosphorylated ITIM sequences on two adjacent Fc␥RIIB receptors.
Our data also suggest that phosphatases do not necessarily require an ITIM for their recruitment to activating receptors. This thesis is derived from our observations that SHP-1 and SHIP-1 in the absence of Fc␥RIIB can inhibit Fc␥RIIA-mediated phagocytosis in transfected COS-1 cells ( Table 1) , and that SHP-1 inhibits tyrosine phosphorylation of Fc␥RIIA (Fig. 1) . Furthermore the phosphatase itself becomes tyrosinephosphorylated following Fc␥RIIA stimulation in COS-1 cells in the absence of Fc␥RIIB (Fig. 4A, lanes 5 and 6) . It is not clear from these studies whether SHP-1, in the absence of an ITIM-containing receptor, interacts directly with Fc␥RIIA or whether SHP-1 is recruited to the receptor complex through an intermediary molecule. We have not observed the coimmunoprecipitation of Fc␥RIIA and SHP-1 in our experiments. Although such an interaction cannot be ruled out (others have detected an association between the inositol phosphatase SHIP-1 and the ␥-chain ITAM sequence in vitro; ref. [30] ), it is possible that a protein such as the Syk kinase may recruit SHP-1 following Fc␥RIIA activation.
Syk kinase is a key activator of the Fc␥RIIA signaling pathway leading to phagocytosis. Our data indicate that tyrosine phosphorylation of Syk in COS-1 cells following Fc␥RIIA/Fc␥RIIB coaggregation is dramatically reduced in the presence of cotransfected SHP-1 (Figs. 2 and 3A) . SHP-1 also inhibited the activation of Syk tyrosine phosphorylation when Syk was coexpressed with Fc␥RIIA and SHP-1 in the absence of Fc␥RIIB (Fig. 3A) . A phosphatase-negative mutant of SHP-1 did not affect Syk tyrosine phosphorylation, suggesting that Syk is a substrate for SHP-1 (Fig. 3) . Phosphorylation of ITAM sequences and the activation of Syk kinase are regarded as the initial steps in the signaling cascade initiated by the activation of Syk and Src-related tyrosine kinases. That Syk kinase activation is inhibited in the presence of overexpressed SHP-1 confirms that SHP-1 is acting at an early stage of the Fc␥RIIA signaling cascade. We have shown that Syk and SHP-1 coimmunoprecipitate both in the presence and absence of Fc␥RIIB (Fig. 2) . Taken together with our previous observations that Syk associates with Fc␥RIIA following Fc␥RIIA stimulation [1] , the data suggest that Syk kinase may play a role in the recruitment of SHP-1.
